Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Melanoma 2Sarcoma 1Melanoma, Cutaneous Malignant 1Hematologic Neoplasms 1Glioma 1

Interventions

trametinib 2dabrafenib 2binimetinib 2Trastuzumab 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cisplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1tipifarnib 1sapanisertib 1romidepsin 1ripretinib 1relatlimab 1pertuzumab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1glutathione pegylated liposomal doxorubicin 1erdafitinib 1entrectinib 1entinostat 1efineptakin alfa 1durvalumab 1defactinib 1copanlisib 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Genetic Testing × Dermatologic × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡